A traditional animal medicine appeared to protect nerve-like cells from a chemical stress linked to brain damage. But the important clue was not simply that more cells survived—it was how the cells’ own cleanup and self-destruction systems changed. Alzheimer’s disease is a progressive disease that initiates with mild memory loss and may progress to full impairment of cognitive and executive functioning.

One in three elderly people dies from Alzheimer’s disease or another form of dementia. The number of people affected is expected to grow, increasing the need for effective treatment strategies. Developing effective treatment strategies for Alzheimer’s disease could also reduce the financial burden of healthcare for patients.

The study used PC12 cells as an Alzheimer’s disease cellular model to investigate whether Moschus protects against glutamate-induced cell injury and to explore how that protection might work. Think of the cells as tiny houses in a storm: the question was whether Moschus could help keep the houses intact while a damaging chemical stress was blowing through.

The chemical components in the Moschus samples were determined by chemical analysis and checked against reference information to confirm their composition. Seventeen chemical ingredients were identified in the Moschus sample. Glutamate stimulation dramatically decreased cell viability compared with the control group, while pretreatment with Moschus notably increased cell viability.

Glutamate stimulation increased the release of a substance associated with damaged cells, while pretreatment with Moschus notably reduced that release. These results showed that Moschus might be protective against glutamate-induced cellular injury in PC12 cells.

The early rate of cell self-destruction markedly increased after glutamate stimulation compared with the control group, while pretreatment with Moschus significantly decreased it. The cell signals associated with self-destruction were strongest after glutamate stimulation and were inhibited after pretreatment with Moschus.

These results indicated that Moschus might protect PC12 cells from glutamate-induced cell self-destruction. Cellular cleanup is the process of digesting cell components. In the glutamate-stimulated group, signals associated with this cleanup increased, while pretreatment with Moschus reduced those signals and increased another signal.

The number of small structures associated with cellular cleanup increased significantly in the glutamate-stimulated group, while the number decreased after pretreatment with Moschus. The mitochondrion is the cell’s energy center and is also vital to cellular cleanup.

A harmful chemical stress sharply reduced the cells’ survival and increased leakage from damaged cells. Giving Moschus beforehand partly preserved survival and reduced that leakage, suggesting it protects cells from this injury. Excess glutamate causes many more cells to begin dying, while pretreatment with Moschus leaves far fewer early dying cells and much weaker death-related staining.

This supports the idea that Moschus protects these cells from glutamate-triggered damage. Modern pharmacology suggests that Moschus has nerve-protecting, self-destruction-limiting, damage-limiting, and immune-supporting activities, and is broadly used in the nervous, cardiovascular, and blood-vessel systems.

The protective effect of Moschus on glutamate-induced cellular damage was investigated, and seventeen chemical compounds from the Moschus sample were identified. In summary, the study found that Moschus might possess a nerve-protective effect in glutamate-induced nerve-cell damage.

Further study of the multiple components of Moschus might provide a potential target for preventing and treating Alzheimer’s disease. In this cell study, Moschus reduced several signs of glutamate-related damage and changed signals linked to cellular cleanup and self-destruction.

That makes it worth further study, but it does not yet show that it treats Alzheimer’s disease in people.